Michael Zimmermann Lab
banner
zimmermannlab.bsky.social
Michael Zimmermann Lab
@zimmermannlab.bsky.social
We use high-throughput MS, bacterial genetics, gnotobiology & computational models to study metabolic interactions in microbial ecosystems
@EMBL

Homepage: https://www.embl.org/groups/zimmermann/
This semester, we also welcomed Luka, the newest PhD candidate of the Zimmermann group!

Luka is coming from Montenegro and will work on high-throughput exploration of the metagenomic sequence space.

Welcome🎉🎊
October 22, 2025 at 4:52 PM
We would like to introduce Daniel who has just started his PhD with us, in which he aims to accelerate high-throughput metabolomics method development to uncover bidirectional interactions between drugs and the human gut microbiome in the context of health and disease. 🦠

Welcome to the team! 🎉
October 16, 2025 at 8:40 AM
Sneak peek: 2 weeks ago, our team presented the GUT-BASE: our new atlas mapping how gut microbes transform drugs.

We profiled thousands of microbe–drug interactions across gut species as a first step toward understanding — and eventually predicting — how the microbiome shapes drug metabolism.
October 7, 2025 at 1:26 PM
Do you have experience in metabolomics/lipidomics/exposomics?

Check out the EMBL ARISE2 Fellowship Programme!
🔗 www.embl.org/training/ari...

📩 Contact: Juan Antonio Vizcaíno — Team Leader, EMBL-EBI
🔗 www.ebi.ac.uk/people/perso...

📌 Applications close soon!
📆 30/09/2025
More info below👇
August 1, 2025 at 2:04 PM
🎓 Congratulations to Dr. Amber Brauer on successfully defending her PhD thesis, “Metabolic Interactions in the Entero-Hepatic Cycle,” supervised by Dr. Michael Zimmermann and Prof. Dr. Anne-Claude Gavin. Thesis Committee: Prof. Pascale Vonaesch and Prof. Mirko Trajkovski.
#Metabolomics #Microbiome
May 22, 2025 at 8:38 AM
Today, at the MSB unit seminar, our MSCA postdoc Anoop Singh spoke about quorum-sensing mediated bacterial interactions and biofilm formation in CRC-associated bacteria.

His findings aim to provide insights into CRC development and aid in developing therapeutics against pathogenic biofilms.
March 28, 2025 at 3:37 PM
Welcome onboard Leyla!
Leyla is our new master's student and she will combine public untargeted metabolomics data & machine learning to predict potential drug biotransformation in gut microbes by highlighting key metabolic interactions.
February 6, 2025 at 10:33 AM
Congratulations to Lenard, our first-year PhD student, for winning one of the poster prizes at the EMBL PhD Symposium! Lenard is off to a great start in his PhD journey! 🚀 @embojournal.org
January 27, 2025 at 1:26 PM